Showing results (31-40 of 283) with videos related to

Sort By:
Pageof 29
Expert Opinion on Drug Safety|July 28, 2020
Safety considerations with targeted therapy drugs for B-cell non-Hodgkin lymphomaShinichi Makita, Rika Hosoba, Kensei Tobinai
Advances in Therapy|February 8, 2018
A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment StrategiesOlivier Hermine, Juan Carlos Ramos, Kensei Tobinai
Future Oncology (London, England)|October 6, 2020
Comparative effectiveness study of chemotherapy in follicular lymphoma patients in the rituximab era: a Japanese claims database studySaaya Tsutsué, Kensei Tobinai, Jingbo Yi, et al.
International Journal of Hematology|October 4, 2016
Fulminant type I diabetes mellitus associated with nivolumab in a patient with relapsed classical Hodgkin lymphomaWataru Munakata, Ken Ohashi, Nobuhiko Yamauchi, et al.
Drugs in Context|March 1, 2019
Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challengesShinichi Makita, Katsuaki Imaizumi, Saiko Kurosawa, et al.
Abdominal Imaging|April 17, 2009
Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: PET/CTUkihide Tateishi, Takashi Terauchi, Tomio Inoue, et al.
Japanese Journal of Clinical Oncology|December 8, 2011
Lymphoma study group of JCOGKunihiro Tsukasaki, Kensei Tobinai, Tomomitu Hotta, et al.
Pageof 29